{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T03:02:33Z","timestamp":1779850953775,"version":"3.53.1"},"reference-count":80,"publisher":"American Dental Society of Anesthesiology (ADSA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:p>Epilepsy and seizure activity in dental patients can pose difficult management and treatment considerations for dental professionals, especially for those utilizing sedation and general anesthesia in office-based settings. This 2-part review will provide an overview of current approaches to managing patients with seizure disorders in dental settings. The first part of this review focuses on categorization, identification, and management strategies for seizure disorders, including pharmacological treatment, surgical intervention, and other emerging therapies. The second part of this review will highlight treatment considerations for patients with seizure disorders undergoing sedation or general anesthesia for dental care, including the effects of sedatives and anesthetic agents on seizure activity, strategies for maintaining seizure control, and management of drug interactions.<\/jats:p>","DOI":"10.2344\/anpr-72-2-seizure-disorder","type":"journal-article","created":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T05:08:16Z","timestamp":1749445696000},"page":"121-130","source":"Crossref","is-referenced-by-count":0,"title":["Perioperative Management of Patients With Seizure Disorders: Part I"],"prefix":"10.2344","volume":"72","author":[{"given":"Caroline M.","family":"Sawicki","sequence":"first","affiliation":[{"name":"Department of Pediatric Dentistry and Dental Public Health, University of North Carolina Adams School of Dentistry, Chapel Hill, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Key","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, University of Texas Health Science Center at Houston, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megann","family":"Smiley","sequence":"additional","affiliation":[{"name":"Private practice, Columbus, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spencer D.","family":"Wade","sequence":"additional","affiliation":[{"name":"Private practice, Raleigh, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1191","reference":[{"key":"i1878-7177-72-2-121-b01","series-title":"Epilepsy Behav","first-page":"109852","article-title":"About 1.5 million community-dwelling US adults with active epilepsy reported uncontrolled seizures in the past 12 months, and seizure control varied by annual family income\u2014National Health Interview Survey, United States 2021 and 2022","volume":"157","author":"Kobau R","year":"2024","unstructured":"Kobau R,\nLuncheon C,\nGreenlund KJ. About 1.5 million community-dwelling US adults with active epilepsy reported uncontrolled seizures in the past 12 months, and seizure control varied by annual family income\u2014National Health Interview Survey, United States 2021 and 2022. Epilepsy Behav. 2024;157:109852. doi:10.1016\/j.yebeh.2024.109852"},{"issue":"7","key":"i1878-7177-72-2-121-b02","series-title":"Am J Med","first-page":"840","article-title":"Epilepsy: a clinical overview","volume":"134","author":"Milligan TA.","year":"2021","unstructured":"Milligan TA. Epilepsy: a clinical overview. Am J Med. 2021;134(7):840\u2013847. doi:10.1016\/j.amjmed.2021.01.038"},{"issue":"2","key":"i1878-7177-72-2-121-b03","series-title":"Curr Opin Neurol","first-page":"130","article-title":"Redefining epilepsy","volume":"28","author":"Fisher RS.","year":"2015","unstructured":"Fisher RS. Redefining epilepsy. Curr Opin Neurol. 2015;28(2):130\u2013135. doi:10.1097\/WCO.0000000000000174"},{"issue":"2","key":"i1878-7177-72-2-121-b04","series-title":"Pediatr Clin North Am","first-page":"257","article-title":"Seizures in children","volume":"53","author":"Friedman MJ","year":"2006","unstructured":"Friedman MJ,\nSharieff GQ. Seizures in children. Pediatr Clin North Am. 2006;53(2):257\u2013277. doi:10.1016\/j.pcl.2005.09.010"},{"issue":"6","key":"i1878-7177-72-2-121-b05","series-title":"Age Ageing","first-page":"442","article-title":"How common are epileptic seizures in old age","volume":"20","author":"Tallis R","year":"1991","unstructured":"Tallis R,\nHall G,\nCraig I,\nDean A. How common are epileptic seizures in old age? Age Ageing. 1991;20(6):442\u2013448. doi:10.1093\/ageing\/20.6.442"},{"issue":"3","key":"i1878-7177-72-2-121-b06","series-title":"Neuropsychopharmacol Rep","first-page":"336","article-title":"Neuropharmacology of antiseizure drugs","volume":"41","author":"Hakami T.","year":"2021","unstructured":"Hakami T. Neuropharmacology of antiseizure drugs. Neuropsychopharmacol Rep. 2021;41(3):336\u2013351. doi:10.1002\/npr2.12196"},{"issue":"suppl 3","key":"i1878-7177-72-2-121-b07","series-title":"Epilepsia","first-page":"8","article-title":"GABAergic mechanisms in epilepsy","volume":"42","author":"Treiman DM.","year":"2001","unstructured":"Treiman DM. GABAergic mechanisms in epilepsy. Epilepsia. 2001;42(suppl 3):8\u201312. doi:10.1046\/j.1528-1157.2001.042suppl.3008.x"},{"issue":"4","key":"i1878-7177-72-2-121-b08","series-title":"Epilepsia","first-page":"531","article-title":"Instruction manual for the ILAE 2017 operational classification of seizure types","volume":"58","author":"Fisher RS","year":"2017","unstructured":"Fisher RS,\nCross JH,\nD\u2019Souza C, et al. Instruction manual for the ILAE 2017 operational classification of seizure types. Epilepsia. 2017;58(4):531\u2013542. doi:10.1111\/epi.13671"},{"key":"i1878-7177-72-2-121-b09","series-title":"Epilepsy Behav","first-page":"108455","article-title":"Seizure semiology, localization, and the 2017 ILAE seizure classification","volume":"126","author":"Turek G","year":"2022","unstructured":"Turek G,\nSkjei K. Seizure semiology, localization, and the 2017 ILAE seizure classification. Epilepsy Behav. 2022;126:108455. doi:10.1016\/j.yebeh.2021.108455"},{"issue":"2","key":"i1878-7177-72-2-121-b10","series-title":"Continuum (Minneap Minn)","first-page":"306","article-title":"Epilepsy Overview and revised classification of seizures and epilepsies","volume":"25","author":"Pack AM.","year":"2019","unstructured":"Pack AM. Epilepsy Overview and revised classification of seizures and epilepsies. Continuum (Minneap Minn). 2019;25(2):306\u2013321. doi:10.1212\/CON.0000000000000707"},{"key":"i1878-7177-72-2-121-b11","series-title":"Epilepsy Behav","first-page":"107306","article-title":"The weather condition and epidemics as triggers for febrile seizure: a single-center retrospective observational study","volume":"111","author":"Kawakami I","year":"2020","unstructured":"Kawakami I,\nInoue M,\nAdachi S,\nKoga H. The weather condition and epidemics as triggers for febrile seizure: a single-center retrospective observational study. Epilepsy Behav. 2020;111:107306. doi:10.1016\/j.yebeh.2020.107306"},{"issue":"8","key":"i1878-7177-72-2-121-b12","series-title":"JAMA","first-page":"823","article-title":"Risk of febrile seizures and epilepsy after vaccination with diphtheria, tetanus, acellular pertussis, inactivated poliovirus, and Haemophilus influenzae type B","volume":"307","author":"Sun Y","year":"2012","unstructured":"Sun Y,\nChristensen J,\nHviid A, et al. Risk of febrile seizures and epilepsy after vaccination with diphtheria, tetanus, acellular pertussis, inactivated poliovirus, and Haemophilus influenzae type B. JAMA. 2012;307(8):823\u2013831. doi:10.1001\/jama.2012.165"},{"issue":"suppl 1","key":"i1878-7177-72-2-121-b13","series-title":"Epilepsia","first-page":"13","article-title":"Risk of recurrence after a first unprovoked seizure","volume":"49","author":"Berg AT.","year":"2008","unstructured":"Berg AT. Risk of recurrence after a first unprovoked seizure. Epilepsia. 2008;49(suppl 1):13\u201318. doi:10.1111\/j.1528-1167.2008.01444.x"},{"issue":"pt 11","key":"i1878-7177-72-2-121-b14","series-title":"Brain","first-page":"2427","article-title":"Life expectancy in people with newly diagnosed epilepsy","volume":"127","author":"Gaitatzis A","year":"2004","unstructured":"Gaitatzis A,\nJohnson AL,\nChadwick DW,\nShorvon SD,\nSander JW. Life expectancy in people with newly diagnosed epilepsy. Brain. 2004;127(pt 11):2427\u20132432. doi:10.1093\/brain\/awh267"},{"key":"i1878-7177-72-2-121-b15","series-title":"Seizure","first-page":"65","article-title":"Sudden unexpected death in epilepsy: the neuro-cardio-respiratory connection","volume":"64","author":"Manolis TA","year":"2019","unstructured":"Manolis TA,\nManolis AA,\nMelita H,\nManolis AS. Sudden unexpected death in epilepsy: the neuro-cardio-respiratory connection. Seizure. 2019;64:65\u201373. doi:10.1016\/j.seizure.2018.12.007"},{"issue":"1","key":"i1878-7177-72-2-121-b16","series-title":"Epilepsy Behav","first-page":"52","article-title":"Detecting health disparities among Caucasians and African-Americans with epilepsy","volume":"20","author":"Bautista RE","year":"2011","unstructured":"Bautista RE,\nJain D. Detecting health disparities among Caucasians and African-Americans with epilepsy. Epilepsy Behav. 2011;20(1):52\u201356. doi:10.1016\/j.yebeh.2010.10.016"},{"key":"i1878-7177-72-2-121-b17","series-title":"Epilepsy Behav","first-page":"28","article-title":"Epilepsy by the numbers: epilepsy deaths by age, race\/ethnicity, and gender in the United States significantly increased from 2005 to 2014","volume":"69","author":"Greenlund SF","year":"2017","unstructured":"Greenlund SF,\nCroft JB,\nKobau R. Epilepsy by the numbers: epilepsy deaths by age, race\/ethnicity, and gender in the United States significantly increased from 2005 to 2014. Epilepsy Behav. 2017;69:28\u201330. doi:10.1016\/j.yebeh.2017.01.016"},{"issue":"6","key":"i1878-7177-72-2-121-b18","series-title":"Epileptic Disord","first-page":"782","article-title":"Mind the gap: health disparities in families living with epilepsy are significant and linked to socioeconomic status","volume":"22","author":"Groover O","year":"2020","unstructured":"Groover O,\nMorton ML,\nJanocko NJ, et al. Mind the gap: health disparities in families living with epilepsy are significant and linked to socioeconomic status. Epileptic Disord. 2020;22(6):782\u2013789. doi:10.1684\/epd.2020.1229"},{"key":"i1878-7177-72-2-121-b19","series-title":"Front Epidemiol","first-page":"1081757","article-title":"Mortality, and life expectancy in epilepsy and status epilepticus\u2014current trends and future aspects","volume":"3","author":"Trinka E","year":"2023","unstructured":"Trinka E,\nRainer LJ,\nGranbichler CA,\nZimmermann G,\nLeitinger M. Mortality, and life expectancy in epilepsy and status epilepticus\u2014current trends and future aspects. Front Epidemiol. 2023;3:1081757. doi:10.3389\/fepid.2023.1081757"},{"issue":"4","key":"i1878-7177-72-2-121-b20","series-title":"J Altern Complement Med","first-page":"367","article-title":"A pilot study of a yoga meditation protocol for patients with medically refractory epilepsy","volume":"12","author":"Rajesh B","year":"2006","unstructured":"Rajesh B,\nJayachandran D,\nMohandas G,\nRadhakrishnan K. A pilot study of a yoga meditation protocol for patients with medically refractory epilepsy. J Altern Complement Med. 2006;12(4):367\u2013371. doi:10.1089\/acm.2006.12.367"},{"key":"i1878-7177-72-2-121-b21","series-title":"Neurosci Lett","first-page":"4","article-title":"How does the ketogenic diet induce anti-seizure effects","volume":"637","author":"Rho JM.","year":"2017","unstructured":"Rho JM. How does the ketogenic diet induce anti-seizure effects? Neurosci Lett. 2017;637:4\u201310. doi:10.1016\/j.neulet.2015.07.034"},{"issue":"10","key":"i1878-7177-72-2-121-b22","series-title":"Nutrients","article-title":"Ketogenic diet and epilepsy","volume":"11","author":"U\u0142amek-Kozio\u0142 M","year":"2019","unstructured":"U\u0142amek-Kozio\u0142 M,\nCzuczwar SJ,\nJanuszewski S,\nPluta R. Ketogenic diet and epilepsy. Nutrients. 2019;11(10). doi:10.3390\/nu11102510"},{"key":"i1878-7177-72-2-121-b23","series-title":"Ann Gen Psychiatry","first-page":"28","article-title":"Depression and anxiety in epilepsy: the association with demographic and seizure-related variables","volume":"6","author":"Kimiskidis VK","year":"2007","unstructured":"Kimiskidis VK,\nTriantafyllou NI,\nKararizou E, et al. Depression and anxiety in epilepsy: the association with demographic and seizure-related variables. Ann Gen Psychiatry. 2007;6:28. doi:10.1186\/1744-859X-6-28"},{"issue":"9","key":"i1878-7177-72-2-121-b24","series-title":"Neurology","first-page":"786","article-title":"Randomized controlled trial of trigeminal nerve stimulation for drug-resistant epilepsy","volume":"80","author":"DeGiorgio CM","year":"2013","unstructured":"DeGiorgio CM,\nSoss J,\nCook IA, et al. Randomized controlled trial of trigeminal nerve stimulation for drug-resistant epilepsy. Neurology. 2013;80(9):786\u2013791. doi:10.1212\/WNL.0b013e318285c11a"},{"issue":"5","key":"i1878-7177-72-2-121-b25","series-title":"Brain Stimul","first-page":"1245","article-title":"External trigeminal nerve stimulation for drug resistant epilepsy: a randomized controlled trial","volume":"13","author":"Gil-L\u00f3pez F","year":"2020","unstructured":"Gil-L\u00f3pez F,\nBoget T,\nManzanares I, et al. External trigeminal nerve stimulation for drug resistant epilepsy: a randomized controlled trial. Brain Stimul. 2020;13(5):1245\u20131253. doi:10.1016\/j.brs.2020.06.005"},{"issue":"15","key":"i1878-7177-72-2-121-b26","series-title":"MMWR Morb Mortal Wkly Rep","first-page":"437","article-title":"Active epilepsy and seizure control in adults\u2014United States, 2013 and 2015","volume":"67","author":"Tian N","year":"2018","unstructured":"Tian N,\nBoring M,\nKobau R,\nZack MM,\nCroft JB. Active epilepsy and seizure control in adults\u2014United States, 2013 and 2015. MMWR Morb Mortal Wkly Rep. 2018;67(15):437\u2013442. doi:10.15585\/mmwr.mm6715a1"},{"issue":"6","key":"i1878-7177-72-2-121-b27","series-title":"Epilepsia","first-page":"1069","article-title":"Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies","volume":"51","author":"Kwan P","year":"2010","unstructured":"Kwan P,\nArzimanoglou A,\nBerg AT, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia. 2010;51(6):1069\u20131077. doi:10.1111\/j.1528-1167.2009.02397.x"},{"issue":"7","key":"i1878-7177-72-2-121-b28","series-title":"JAMA","first-page":"681","article-title":"Review of antiseizure medications for adults with epilepsy\u2014reply","volume":"328","author":"Kanner AM","year":"2022","unstructured":"Kanner AM,\nBicchi MM. Review of antiseizure medications for adults with epilepsy\u2014reply. JAMA. 2022;328(7):681. doi:10.1001\/jama.2022.10600"},{"issue":"2","key":"i1878-7177-72-2-121-b29","series-title":"Neurology","first-page":"145","article-title":"Falls and fractures in patients chronically treated with antiepileptic drugs","volume":"79","author":"Shiek Ahmad B","year":"2012","unstructured":"Shiek Ahmad B,\nHill KD,\nO\u2019Brien TJ,\nGorelik A,\nHabib N,\nWark JD. Falls and fractures in patients chronically treated with antiepileptic drugs. Neurology. 10 2012;79(2):145\u2013151. doi:10.1212\/WNL.0b013e31825f0466"},{"key":"i1878-7177-72-2-121-b30","series-title":"Pharmacology and Therapeutics for Dentistry","author":"Yagiela JA","year":"1998","unstructured":"Yagiela JA,\nNeidle EA,\nDowd FJ. Pharmacology and Therapeutics for Dentistry. 4th ed. Mosby; 1998."},{"key":"i1878-7177-72-2-121-b31","series-title":"Continuum (Minneap Minn)","first-page":"3 epilepsy):643","article-title":"Antiepileptic drug treatment: new drugs and new strategies","volume":"19","author":"French JA","year":"2013","unstructured":"French JA,\nGazzola DM. Antiepileptic drug treatment: new drugs and new strategies. Continuum (Minneap Minn). 2013;19(3 epilepsy):643\u2013655. doi:10.1212\/01.CON.0000431380.21685.75"},{"issue":"6","key":"i1878-7177-72-2-121-b32","series-title":"Neurol Sci","first-page":"2249","article-title":"The surgical treatment of epilepsy","volume":"42","author":"Consales A","year":"2021","unstructured":"Consales A,\nCasciato S,\nAsioli S, et al. The surgical treatment of epilepsy. Neurol Sci. 2021;42(6):2249\u20132260. doi:10.1007\/s10072-021-05198-y"},{"issue":"9","key":"i1878-7177-72-2-121-b33","series-title":"Lancet Neurol","first-page":"748","article-title":"Seizure outcome and use of antiepileptic drugs after epilepsy surgery according to histopathological diagnosis: a retrospective multicentre cohort study","volume":"19","author":"Lamberink HJ","year":"2020","unstructured":"Lamberink HJ,\nOtte WM,\nBl\u00fcmcke I, et al. Seizure outcome and use of antiepileptic drugs after epilepsy surgery according to histopathological diagnosis: a retrospective multicentre cohort study. Lancet Neurol. 2020;19(9):748\u2013757. doi:10.1016\/S1474-4422(20)30220-9"},{"issue":"5","key":"i1878-7177-72-2-121-b34","series-title":"N Engl J Med","first-page":"311","article-title":"A randomized, controlled trial of surgery for temporal-lobe epilepsy","volume":"345","author":"Wiebe S","year":"2001","unstructured":"Wiebe S,\nBlume WT,\nGirvin JP,\nEliasziw M; Effectiveness and Efficiency of Surgery for Temporal Lobe Epilepsy Study Group. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med. 2001;345(5):311\u2013318. doi:10.1056\/NEJM200108023450501"},{"issue":"1","key":"i1878-7177-72-2-121-b35","series-title":"J Epilepsy Res","first-page":"1","article-title":"Hemispherotomy and functional hemispherectomy: indications and outcomes","volume":"8","author":"Kim JS","year":"2018","unstructured":"Kim JS,\nPark EK,\nShim KW,\nKim DS. Hemispherotomy and functional hemispherectomy: indications and outcomes. J Epilepsy Res. 2018;8(1):1\u20135. doi:10.14581\/jer.18001"},{"issue":"8","key":"i1878-7177-72-2-121-b36","series-title":"Curr Neurol Neurosci Rep","first-page":"459","article-title":"Surgical treatment of drug-resistant generalized epilepsy","volume":"22","author":"Bullinger KL","year":"2022","unstructured":"Bullinger KL,\nAlwaki A,\nGross RE. Surgical treatment of drug-resistant generalized epilepsy. Curr Neurol Neurosci Rep. 2022;22(8):459\u2013465. doi:10.1007\/s11910-022-01210-w"},{"issue":"6","key":"i1878-7177-72-2-121-b37","series-title":"J Neurosurg","first-page":"1248","article-title":"Vagus nerve stimulation for epilepsy: a meta-analysis of efficacy and predictors of response","volume":"115","author":"Englot DJ","year":"2011","unstructured":"Englot DJ,\nChang EF,\nAuguste KI. Vagus nerve stimulation for epilepsy: a meta-analysis of efficacy and predictors of response. J Neurosurg. 2011;115(6):1248\u20131255. doi:10.3171\/2011.7.JNS11977"},{"issue":"8","key":"i1878-7177-72-2-121-b38","series-title":"Neuromodulation","first-page":"1742","article-title":"Combined neuromodulation (vagus nerve stimulation and deep brain stimulation) in patients with refractory generalized epilepsy: an observational study","volume":"26","author":"Cukiert A","year":"2023","unstructured":"Cukiert A,\nCukiert CM,\nBurattini JA,\nGuimaraes RB. Combined neuromodulation (vagus nerve stimulation and deep brain stimulation) in patients with refractory generalized epilepsy: an observational study. Neuromodulation. 2023;26(8):1742\u20131746. doi:10.1016\/j.neurom.2022.08.449"},{"issue":"4","key":"i1878-7177-72-2-121-b39","series-title":"Epilepsia","first-page":"811","article-title":"Neurostimulation in generalized epilepsy: a systematic review and meta-analysis","volume":"64","author":"Haneef Z","year":"2023","unstructured":"Haneef Z,\nSkrehot HC. Neurostimulation in generalized epilepsy: a systematic review and meta-analysis. Epilepsia. 2023;64(4):811\u2013820. doi:10.1111\/epi.17524"},{"key":"i1878-7177-72-2-121-b40","series-title":"Behav Neurol","first-page":"2064027","article-title":"Mechanisms Underlying Aggressive Behavior Induced by Antiepileptic Drugs: Focus on Topiramate, Levetiracetam, and Perampanel","author":"Hansen CC","year":"2018","unstructured":"Hansen CC,\nLjung H,\nBrodtkorb E,\nReimers A. Mechanisms Underlying Aggressive Behavior Induced by Antiepileptic Drugs: Focus on Topiramate, Levetiracetam, and Perampanel. Behav Neurol. 2018, 2018:2064027. doi:10.1155\/2018\/2064027"},{"key":"i1878-7177-72-2-121-b01","series-title":"Epilepsy Behav","first-page":"109852","article-title":"About 1.5 million community-dwelling US adults with active epilepsy reported uncontrolled seizures in the past 12 months, and seizure control varied by annual family income\u2014National Health Interview Survey, United States 2021 and 2022","volume":"157","author":"Kobau R","year":"2024","unstructured":"Kobau R,\nLuncheon C,\nGreenlund KJ. About 1.5 million community-dwelling US adults with active epilepsy reported uncontrolled seizures in the past 12 months, and seizure control varied by annual family income\u2014National Health Interview Survey, United States 2021 and 2022. Epilepsy Behav. 2024;157:109852. doi:10.1016\/j.yebeh.2024.109852"},{"issue":"7","key":"i1878-7177-72-2-121-b02","series-title":"Am J Med","first-page":"840","article-title":"Epilepsy: a clinical overview","volume":"134","author":"Milligan TA.","year":"2021","unstructured":"Milligan TA. Epilepsy: a clinical overview. Am J Med. 2021;134(7):840\u2013847. doi:10.1016\/j.amjmed.2021.01.038"},{"issue":"2","key":"i1878-7177-72-2-121-b03","series-title":"Curr Opin Neurol","first-page":"130","article-title":"Redefining epilepsy","volume":"28","author":"Fisher RS.","year":"2015","unstructured":"Fisher RS. Redefining epilepsy. Curr Opin Neurol. 2015;28(2):130\u2013135. doi:10.1097\/WCO.0000000000000174"},{"issue":"2","key":"i1878-7177-72-2-121-b04","series-title":"Pediatr Clin North Am","first-page":"257","article-title":"Seizures in children","volume":"53","author":"Friedman MJ","year":"2006","unstructured":"Friedman MJ,\nSharieff GQ. Seizures in children. Pediatr Clin North Am. 2006;53(2):257\u2013277. doi:10.1016\/j.pcl.2005.09.010"},{"issue":"6","key":"i1878-7177-72-2-121-b05","series-title":"Age Ageing","first-page":"442","article-title":"How common are epileptic seizures in old age","volume":"20","author":"Tallis R","year":"1991","unstructured":"Tallis R,\nHall G,\nCraig I,\nDean A. How common are epileptic seizures in old age? Age Ageing. 1991;20(6):442\u2013448. doi:10.1093\/ageing\/20.6.442"},{"issue":"3","key":"i1878-7177-72-2-121-b06","series-title":"Neuropsychopharmacol Rep","first-page":"336","article-title":"Neuropharmacology of antiseizure drugs","volume":"41","author":"Hakami T.","year":"2021","unstructured":"Hakami T. Neuropharmacology of antiseizure drugs. Neuropsychopharmacol Rep. 2021;41(3):336\u2013351. doi:10.1002\/npr2.12196"},{"issue":"suppl 3","key":"i1878-7177-72-2-121-b07","series-title":"Epilepsia","first-page":"8","article-title":"GABAergic mechanisms in epilepsy","volume":"42","author":"Treiman DM.","year":"2001","unstructured":"Treiman DM. GABAergic mechanisms in epilepsy. Epilepsia. 2001;42(suppl 3):8\u201312. doi:10.1046\/j.1528-1157.2001.042suppl.3008.x"},{"issue":"4","key":"i1878-7177-72-2-121-b08","series-title":"Epilepsia","first-page":"531","article-title":"Instruction manual for the ILAE 2017 operational classification of seizure types","volume":"58","author":"Fisher RS","year":"2017","unstructured":"Fisher RS,\nCross JH,\nD\u2019Souza C, et al. Instruction manual for the ILAE 2017 operational classification of seizure types. Epilepsia. 2017;58(4):531\u2013542. doi:10.1111\/epi.13671"},{"key":"i1878-7177-72-2-121-b09","series-title":"Epilepsy Behav","first-page":"108455","article-title":"Seizure semiology, localization, and the 2017 ILAE seizure classification","volume":"126","author":"Turek G","year":"2022","unstructured":"Turek G,\nSkjei K. Seizure semiology, localization, and the 2017 ILAE seizure classification. Epilepsy Behav. 2022;126:108455. doi:10.1016\/j.yebeh.2021.108455"},{"issue":"2","key":"i1878-7177-72-2-121-b10","series-title":"Continuum (Minneap Minn)","first-page":"306","article-title":"Epilepsy Overview and revised classification of seizures and epilepsies","volume":"25","author":"Pack AM.","year":"2019","unstructured":"Pack AM. Epilepsy Overview and revised classification of seizures and epilepsies. Continuum (Minneap Minn). 2019;25(2):306\u2013321. doi:10.1212\/CON.0000000000000707"},{"key":"i1878-7177-72-2-121-b11","series-title":"Epilepsy Behav","first-page":"107306","article-title":"The weather condition and epidemics as triggers for febrile seizure: a single-center retrospective observational study","volume":"111","author":"Kawakami I","year":"2020","unstructured":"Kawakami I,\nInoue M,\nAdachi S,\nKoga H. The weather condition and epidemics as triggers for febrile seizure: a single-center retrospective observational study. Epilepsy Behav. 2020;111:107306. doi:10.1016\/j.yebeh.2020.107306"},{"issue":"8","key":"i1878-7177-72-2-121-b12","series-title":"JAMA","first-page":"823","article-title":"Risk of febrile seizures and epilepsy after vaccination with diphtheria, tetanus, acellular pertussis, inactivated poliovirus, and Haemophilus influenzae type B","volume":"307","author":"Sun Y","year":"2012","unstructured":"Sun Y,\nChristensen J,\nHviid A, et al. Risk of febrile seizures and epilepsy after vaccination with diphtheria, tetanus, acellular pertussis, inactivated poliovirus, and Haemophilus influenzae type B. JAMA. 2012;307(8):823\u2013831. doi:10.1001\/jama.2012.165"},{"issue":"suppl 1","key":"i1878-7177-72-2-121-b13","series-title":"Epilepsia","first-page":"13","article-title":"Risk of recurrence after a first unprovoked seizure","volume":"49","author":"Berg AT.","year":"2008","unstructured":"Berg AT. Risk of recurrence after a first unprovoked seizure. Epilepsia. 2008;49(suppl 1):13\u201318. doi:10.1111\/j.1528-1167.2008.01444.x"},{"issue":"pt 11","key":"i1878-7177-72-2-121-b14","series-title":"Brain","first-page":"2427","article-title":"Life expectancy in people with newly diagnosed epilepsy","volume":"127","author":"Gaitatzis A","year":"2004","unstructured":"Gaitatzis A,\nJohnson AL,\nChadwick DW,\nShorvon SD,\nSander JW. Life expectancy in people with newly diagnosed epilepsy. Brain. 2004;127(pt 11):2427\u20132432. doi:10.1093\/brain\/awh267"},{"key":"i1878-7177-72-2-121-b15","series-title":"Seizure","first-page":"65","article-title":"Sudden unexpected death in epilepsy: the neuro-cardio-respiratory connection","volume":"64","author":"Manolis TA","year":"2019","unstructured":"Manolis TA,\nManolis AA,\nMelita H,\nManolis AS. Sudden unexpected death in epilepsy: the neuro-cardio-respiratory connection. Seizure. 2019;64:65\u201373. doi:10.1016\/j.seizure.2018.12.007"},{"issue":"1","key":"i1878-7177-72-2-121-b16","series-title":"Epilepsy Behav","first-page":"52","article-title":"Detecting health disparities among Caucasians and African-Americans with epilepsy","volume":"20","author":"Bautista RE","year":"2011","unstructured":"Bautista RE,\nJain D. Detecting health disparities among Caucasians and African-Americans with epilepsy. Epilepsy Behav. 2011;20(1):52\u201356. doi:10.1016\/j.yebeh.2010.10.016"},{"key":"i1878-7177-72-2-121-b17","series-title":"Epilepsy Behav","first-page":"28","article-title":"Epilepsy by the numbers: epilepsy deaths by age, race\/ethnicity, and gender in the United States significantly increased from 2005 to 2014","volume":"69","author":"Greenlund SF","year":"2017","unstructured":"Greenlund SF,\nCroft JB,\nKobau R. Epilepsy by the numbers: epilepsy deaths by age, race\/ethnicity, and gender in the United States significantly increased from 2005 to 2014. Epilepsy Behav. 2017;69:28\u201330. doi:10.1016\/j.yebeh.2017.01.016"},{"issue":"6","key":"i1878-7177-72-2-121-b18","series-title":"Epileptic Disord","first-page":"782","article-title":"Mind the gap: health disparities in families living with epilepsy are significant and linked to socioeconomic status","volume":"22","author":"Groover O","year":"2020","unstructured":"Groover O,\nMorton ML,\nJanocko NJ, et al. Mind the gap: health disparities in families living with epilepsy are significant and linked to socioeconomic status. Epileptic Disord. 2020;22(6):782\u2013789. doi:10.1684\/epd.2020.1229"},{"key":"i1878-7177-72-2-121-b19","series-title":"Front Epidemiol","first-page":"1081757","article-title":"Mortality, and life expectancy in epilepsy and status epilepticus\u2014current trends and future aspects","volume":"3","author":"Trinka E","year":"2023","unstructured":"Trinka E,\nRainer LJ,\nGranbichler CA,\nZimmermann G,\nLeitinger M. Mortality, and life expectancy in epilepsy and status epilepticus\u2014current trends and future aspects. Front Epidemiol. 2023;3:1081757. doi:10.3389\/fepid.2023.1081757"},{"issue":"4","key":"i1878-7177-72-2-121-b20","series-title":"J Altern Complement Med","first-page":"367","article-title":"A pilot study of a yoga meditation protocol for patients with medically refractory epilepsy","volume":"12","author":"Rajesh B","year":"2006","unstructured":"Rajesh B,\nJayachandran D,\nMohandas G,\nRadhakrishnan K. A pilot study of a yoga meditation protocol for patients with medically refractory epilepsy. J Altern Complement Med. 2006;12(4):367\u2013371. doi:10.1089\/acm.2006.12.367"},{"key":"i1878-7177-72-2-121-b21","series-title":"Neurosci Lett","first-page":"4","article-title":"How does the ketogenic diet induce anti-seizure effects","volume":"637","author":"Rho JM.","year":"2017","unstructured":"Rho JM. How does the ketogenic diet induce anti-seizure effects? Neurosci Lett. 2017;637:4\u201310. doi:10.1016\/j.neulet.2015.07.034"},{"issue":"10","key":"i1878-7177-72-2-121-b22","series-title":"Nutrients","article-title":"Ketogenic diet and epilepsy","volume":"11","author":"U\u0142amek-Kozio\u0142 M","year":"2019","unstructured":"U\u0142amek-Kozio\u0142 M,\nCzuczwar SJ,\nJanuszewski S,\nPluta R. Ketogenic diet and epilepsy. Nutrients. 2019;11(10). doi:10.3390\/nu11102510"},{"key":"i1878-7177-72-2-121-b23","series-title":"Ann Gen Psychiatry","first-page":"28","article-title":"Depression and anxiety in epilepsy: the association with demographic and seizure-related variables","volume":"6","author":"Kimiskidis VK","year":"2007","unstructured":"Kimiskidis VK,\nTriantafyllou NI,\nKararizou E, et al. Depression and anxiety in epilepsy: the association with demographic and seizure-related variables. Ann Gen Psychiatry. 2007;6:28. doi:10.1186\/1744-859X-6-28"},{"issue":"9","key":"i1878-7177-72-2-121-b24","series-title":"Neurology","first-page":"786","article-title":"Randomized controlled trial of trigeminal nerve stimulation for drug-resistant epilepsy","volume":"80","author":"DeGiorgio CM","year":"2013","unstructured":"DeGiorgio CM,\nSoss J,\nCook IA, et al. Randomized controlled trial of trigeminal nerve stimulation for drug-resistant epilepsy. Neurology. 2013;80(9):786\u2013791. doi:10.1212\/WNL.0b013e318285c11a"},{"issue":"5","key":"i1878-7177-72-2-121-b25","series-title":"Brain Stimul","first-page":"1245","article-title":"External trigeminal nerve stimulation for drug resistant epilepsy: a randomized controlled trial","volume":"13","author":"Gil-L\u00f3pez F","year":"2020","unstructured":"Gil-L\u00f3pez F,\nBoget T,\nManzanares I, et al. External trigeminal nerve stimulation for drug resistant epilepsy: a randomized controlled trial. Brain Stimul. 2020;13(5):1245\u20131253. doi:10.1016\/j.brs.2020.06.005"},{"issue":"15","key":"i1878-7177-72-2-121-b26","series-title":"MMWR Morb Mortal Wkly Rep","first-page":"437","article-title":"Active epilepsy and seizure control in adults\u2014United States, 2013 and 2015","volume":"67","author":"Tian N","year":"2018","unstructured":"Tian N,\nBoring M,\nKobau R,\nZack MM,\nCroft JB. Active epilepsy and seizure control in adults\u2014United States, 2013 and 2015. MMWR Morb Mortal Wkly Rep. 2018;67(15):437\u2013442. doi:10.15585\/mmwr.mm6715a1"},{"issue":"6","key":"i1878-7177-72-2-121-b27","series-title":"Epilepsia","first-page":"1069","article-title":"Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies","volume":"51","author":"Kwan P","year":"2010","unstructured":"Kwan P,\nArzimanoglou A,\nBerg AT, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia. 2010;51(6):1069\u20131077. doi:10.1111\/j.1528-1167.2009.02397.x"},{"issue":"7","key":"i1878-7177-72-2-121-b28","series-title":"JAMA","first-page":"681","article-title":"Review of antiseizure medications for adults with epilepsy\u2014reply","volume":"328","author":"Kanner AM","year":"2022","unstructured":"Kanner AM,\nBicchi MM. Review of antiseizure medications for adults with epilepsy\u2014reply. JAMA. 2022;328(7):681. doi:10.1001\/jama.2022.10600"},{"issue":"2","key":"i1878-7177-72-2-121-b29","series-title":"Neurology","first-page":"145","article-title":"Falls and fractures in patients chronically treated with antiepileptic drugs","volume":"79","author":"Shiek Ahmad B","year":"2012","unstructured":"Shiek Ahmad B,\nHill KD,\nO\u2019Brien TJ,\nGorelik A,\nHabib N,\nWark JD. Falls and fractures in patients chronically treated with antiepileptic drugs. Neurology. 10 2012;79(2):145\u2013151. doi:10.1212\/WNL.0b013e31825f0466"},{"key":"i1878-7177-72-2-121-b30","series-title":"Pharmacology and Therapeutics for Dentistry","author":"Yagiela JA","year":"1998","unstructured":"Yagiela JA,\nNeidle EA,\nDowd FJ. Pharmacology and Therapeutics for Dentistry. 4th ed. Mosby; 1998."},{"key":"i1878-7177-72-2-121-b31","series-title":"Continuum (Minneap Minn)","first-page":"3 epilepsy):643","article-title":"Antiepileptic drug treatment: new drugs and new strategies","volume":"19","author":"French JA","year":"2013","unstructured":"French JA,\nGazzola DM. Antiepileptic drug treatment: new drugs and new strategies. Continuum (Minneap Minn). 2013;19(3 epilepsy):643\u2013655. doi:10.1212\/01.CON.0000431380.21685.75"},{"issue":"6","key":"i1878-7177-72-2-121-b32","series-title":"Neurol Sci","first-page":"2249","article-title":"The surgical treatment of epilepsy","volume":"42","author":"Consales A","year":"2021","unstructured":"Consales A,\nCasciato S,\nAsioli S, et al. The surgical treatment of epilepsy. Neurol Sci. 2021;42(6):2249\u20132260. doi:10.1007\/s10072-021-05198-y"},{"issue":"9","key":"i1878-7177-72-2-121-b33","series-title":"Lancet Neurol","first-page":"748","article-title":"Seizure outcome and use of antiepileptic drugs after epilepsy surgery according to histopathological diagnosis: a retrospective multicentre cohort study","volume":"19","author":"Lamberink HJ","year":"2020","unstructured":"Lamberink HJ,\nOtte WM,\nBl\u00fcmcke I, et al. Seizure outcome and use of antiepileptic drugs after epilepsy surgery according to histopathological diagnosis: a retrospective multicentre cohort study. Lancet Neurol. 2020;19(9):748\u2013757. doi:10.1016\/S1474-4422(20)30220-9"},{"issue":"5","key":"i1878-7177-72-2-121-b34","series-title":"N Engl J Med","first-page":"311","article-title":"A randomized, controlled trial of surgery for temporal-lobe epilepsy","volume":"345","author":"Wiebe S","year":"2001","unstructured":"Wiebe S,\nBlume WT,\nGirvin JP,\nEliasziw M; Effectiveness and Efficiency of Surgery for Temporal Lobe Epilepsy Study Group. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med. 2001;345(5):311\u2013318. doi:10.1056\/NEJM200108023450501"},{"issue":"1","key":"i1878-7177-72-2-121-b35","series-title":"J Epilepsy Res","first-page":"1","article-title":"Hemispherotomy and functional hemispherectomy: indications and outcomes","volume":"8","author":"Kim JS","year":"2018","unstructured":"Kim JS,\nPark EK,\nShim KW,\nKim DS. Hemispherotomy and functional hemispherectomy: indications and outcomes. J Epilepsy Res. 2018;8(1):1\u20135. doi:10.14581\/jer.18001"},{"issue":"8","key":"i1878-7177-72-2-121-b36","series-title":"Curr Neurol Neurosci Rep","first-page":"459","article-title":"Surgical treatment of drug-resistant generalized epilepsy","volume":"22","author":"Bullinger KL","year":"2022","unstructured":"Bullinger KL,\nAlwaki A,\nGross RE. Surgical treatment of drug-resistant generalized epilepsy. Curr Neurol Neurosci Rep. 2022;22(8):459\u2013465. doi:10.1007\/s11910-022-01210-w"},{"issue":"6","key":"i1878-7177-72-2-121-b37","series-title":"J Neurosurg","first-page":"1248","article-title":"Vagus nerve stimulation for epilepsy: a meta-analysis of efficacy and predictors of response","volume":"115","author":"Englot DJ","year":"2011","unstructured":"Englot DJ,\nChang EF,\nAuguste KI. Vagus nerve stimulation for epilepsy: a meta-analysis of efficacy and predictors of response. J Neurosurg. 2011;115(6):1248\u20131255. doi:10.3171\/2011.7.JNS11977"},{"issue":"8","key":"i1878-7177-72-2-121-b38","series-title":"Neuromodulation","first-page":"1742","article-title":"Combined neuromodulation (vagus nerve stimulation and deep brain stimulation) in patients with refractory generalized epilepsy: an observational study","volume":"26","author":"Cukiert A","year":"2023","unstructured":"Cukiert A,\nCukiert CM,\nBurattini JA,\nGuimaraes RB. Combined neuromodulation (vagus nerve stimulation and deep brain stimulation) in patients with refractory generalized epilepsy: an observational study. Neuromodulation. 2023;26(8):1742\u20131746. doi:10.1016\/j.neurom.2022.08.449"},{"issue":"4","key":"i1878-7177-72-2-121-b39","series-title":"Epilepsia","first-page":"811","article-title":"Neurostimulation in generalized epilepsy: a systematic review and meta-analysis","volume":"64","author":"Haneef Z","year":"2023","unstructured":"Haneef Z,\nSkrehot HC. Neurostimulation in generalized epilepsy: a systematic review and meta-analysis. Epilepsia. 2023;64(4):811\u2013820. doi:10.1111\/epi.17524"},{"key":"i1878-7177-72-2-121-b40","series-title":"Behav Neurol","first-page":"2064027","article-title":"Mechanisms Underlying Aggressive Behavior Induced by Antiepileptic Drugs: Focus on Topiramate, Levetiracetam, and Perampanel","author":"Hansen CC","year":"2018","unstructured":"Hansen CC,\nLjung H,\nBrodtkorb E,\nReimers A. Mechanisms Underlying Aggressive Behavior Induced by Antiepileptic Drugs: Focus on Topiramate, Levetiracetam, and Perampanel. Behav Neurol. 2018, 2018:2064027. doi:10.1155\/2018\/2064027"}],"container-title":["Anesthesia Progress"],"original-title":[],"link":[{"URL":"https:\/\/anesthesiaprogress.kglmeridian.com\/view\/journals\/anpr\/72\/2\/article-p121.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/anesthesiaprogress.kglmeridian.com\/downloadpdf\/journals\/anpr\/72\/2\/article-p121.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/anesthesiaprogress.kglmeridian.com\/downloadpdf\/journals\/anpr\/72\/2\/article-p121.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T02:20:06Z","timestamp":1779848406000},"score":1,"resource":{"primary":{"URL":"https:\/\/anesthesiaprogress.kglmeridian.com\/view\/journals\/anpr\/72\/2\/article-p121.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":80,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.2344\/anpr-72-2-seizure-disorder","relation":{},"ISSN":["1878-7177","0003-3006"],"issn-type":[{"value":"1878-7177","type":"electronic"},{"value":"0003-3006","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]}}}